Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2019 Filed Feb 25, 2019 19:22 UTC |
JOHNSON R MILTONDirector · Chairman
|
GrantCommon Stock | 73,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013236 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,929 F1 · kind: On January 29, 2016, the reporting person was granted 60,020 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:21 UTC | Tax withholdingCommon Stock | 9,278 | $142.01 | $1,317,568.78 |
DisclosureSEC source: 0001209191-19-013234 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,981 Read SEC document |
|
| February 21, 2019 Filed Feb 25, 2019 19:21 UTC | GrantCommon Stock | 26,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013234 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,259 F1 · kind: On January 29, 2016, the reporting person was granted 21,480 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
|
| February 21, 2019 Filed Feb 25, 2019 19:20 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 3,219 | $142.01 | $457,130.19 |
DisclosureSEC source: 0001209191-19-013232 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,719 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:20 UTC |
Hall Charles JGroup President
|
GrantCommon Stock | 10,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013232 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,938 F1 · kind: On January 29, 2016, the reporting person was granted 8,850 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:19 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 4,258 | $142.01 | $604,678.58 |
DisclosureSEC source: 0001209191-19-013228 · doc4.xml · nonDerivative · entry 3 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,905 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:19 UTC |
Foster Jon MGroup President
|
GrantCommon Stock | 10,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013228 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,163 F1 · kind: On January 29, 2016, the reporting person was granted 8,850 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:18 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 1,163 | $142.01 | $165,157.63 |
DisclosureSEC source: 0001209191-19-013226 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,986 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:18 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GrantCommon Stock | 4,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013226 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,149 F1 · kind: On January 29, 2016, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:17 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 2,620 | $142.01 | $372,066.20 |
DisclosureSEC source: 0001209191-19-013225 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,597.913 F2 · balance_after: Includes 1,632.9130 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:17 UTC |
Cuffe Michael S.President-Physician Services
|
GrantCommon Stock | 9,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013225 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,217.913 F1 · kind: On January 29, 2016, the reporting person was granted 7,590 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. F2 · balance_after: Includes 1,632.9130 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Tax withholdingCommon Stock | 807 | $142.01 | $114,602.07 |
DisclosureSEC source: 0001209191-19-013223 · doc4.xml · nonDerivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,211.4098 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC |
Billington Phillip GSVP-Internal Audit Services
|
GrantCommon Stock | 3,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013223 · doc4.xml · nonDerivative · entry 1 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,018.4098 F1 · kind: On January 29, 2016, the reporting person was granted 2,600 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| February 14, 2019 Filed Feb 25, 2019 19:19 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013228 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,344 Read SEC document |
| February 13, 2019 Filed Feb 13, 2019 20:31 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 21,304 | $140.89 | $3,001,435.34 |
DisclosureSEC source: 0001209191-19-009921 · doc4.xml · nonDerivative · entry 4 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,852 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.76 to $141.32, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 20:31 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 11,640 | $139.68 | $1,625,874.04 |
DisclosureSEC source: 0001209191-19-009921 · doc4.xml · nonDerivative · entry 3 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,156 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.51 to $139.88, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 18:16 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-19-010406 · doc4.xml · derivative · entry 6 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 18:16 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-19-010406 · doc4.xml · derivative · entry 5 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 18:16 UTC |
RUTHERFORD BILL BCFO and EVP
|
SaleCommon Stock | 37,500 | $139.65 | $5,236,691.25 |
DisclosureSEC source: 0001209191-19-010406 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,472 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.27 to $139.93, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 18:16 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 37,500 | $17.33 | $649,875.00 |
DisclosureSEC source: 0001209191-19-010406 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 18:01 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
SaleCommon Stock | 33,670 | $140.05 | $4,715,530.64 |
DisclosureSEC source: 0001209191-19-010369 · doc4.xml · nonDerivative · entry 1 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,734 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.32, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 18:00 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 8,368 | $139.47 | $1,167,085.80 |
DisclosureSEC source: 0001209191-19-010368 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,237 Read SEC document |
| February 11, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
SaleCommon Stock | 28,084 | $138.97 | $3,902,948.62 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 7 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,868 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.74 to $139.13, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 20:31 UTC |
Foster Jon MGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 40,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-19-009921 · doc4.xml · derivative · entry 9 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 20:31 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 18,696 | $138.66 | $2,592,387.36 |
DisclosureSEC source: 0001209191-19-009921 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,796 Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 20:31 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 40,000 | $22.95 | $918,000.00 |
DisclosureSEC source: 0001209191-19-009921 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2019 Filed Nov 4, 2019 18:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 19,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055029 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By JMF Family Trust (Spouse, Trustee) Disclosed balance after: 19,985 Read SEC document |
| February 11, 2019 Filed Nov 4, 2019 18:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 19,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055029 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By 2016 GRAT (Spouse, Trustee) Disclosed balance after: 0 Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:38 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
SaleCommon Stock | 263 | $140.60 | $36,978.77 |
DisclosureSEC source: 0001209191-19-009136 · doc4.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,659.3464 Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:39 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 35,625 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-009137 · doc4.xml · derivative · entry 7 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,625 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:39 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 37,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-009137 · doc4.xml · derivative · entry 6 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:39 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Tax withholdingCommon Stock | 39,455 | $140.62 | $5,548,162.10 |
DisclosureSEC source: 0001209191-19-009137 · doc4.xml · nonDerivative · entry 2 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,404 Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:39 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 73,125 | $37.18 | $2,718,787.50 |
DisclosureSEC source: 0001209191-19-009137 · doc4.xml · nonDerivative · entry 1 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 4,575 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · derivative · entry 18 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,725 Underlying: Common Stock · 4,575 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 7,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · derivative · entry 17 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,340 Underlying: Common Stock · 7,340 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 10,245 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · derivative · entry 16 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,415 Underlying: Common Stock · 10,245 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 15,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · derivative · entry 15 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 19,125 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · derivative · entry 14 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,125 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 22,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · derivative · entry 13 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Tax withholdingCommon Stock | 50,701 | $140.62 | $7,129,574.62 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 6 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,952 Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionCommon Stock | 4,575 | $101.16 | $462,807.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 5 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionCommon Stock | 7,340 | $81.96 | $601,586.40 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 4 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionCommon Stock | 10,245 | $69.58 | $712,847.10 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 3 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionCommon Stock | 15,000 | $68.96 | $1,034,400.00 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 2 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 19:37 UTC |
CAMPBELL VICTOR LSVP-Government Affairs
|
Exercise / conversionCommon Stock | 41,625 | $47.97 | $1,996,751.25 |
DisclosureSEC source: 0001209191-19-009135 · doc4.xml · nonDerivative · entry 1 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Government Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:52 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
SaleCommon Stock | 200 | $139.48 | $27,896.00 |
DisclosureSEC source: 0001209191-19-008594 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,231 Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:52 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GiftCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008594 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,431 Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 16:53 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 466 | $139.07 | $64,806.62 |
DisclosureSEC source: 0001209191-19-007386 · doc4.xml · nonDerivative · entry 3 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,432 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 17:41 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 4,575 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-19-008176 · doc4.xml · derivative · entry 11 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,725 Underlying: Common Stock · 4,575 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 17:41 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 7,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-19-008176 · doc4.xml · derivative · entry 10 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,340 Underlying: Common Stock · 7,340 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.